Letter in response to commentary by Small and Cronin

Affiliations

¹ Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA. Electronic address: Lkg6@cdc.gov.
² Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.

Comment

Lisa Grohskopf et al. Vaccine. 2017.

. 2017 Sep 18;35(39):5225.

doi: 10.1016/j.vaccine.2017.07.112.

¹ Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA. Electronic address: Lkg6@cdc.gov.
² Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.

No abstract available

Comment in

Response to letter by Grohskopf et al. in response to commentary by Small and Cronin.
Cronin BJ, Small PA Jr. Cronin BJ, et al. Vaccine. 2017 Sep 18;35(39):5226. doi: 10.1016/j.vaccine.2017.07.114. Vaccine. 2017. PMID: 28867045 No abstract available.

Prevention and Control of Seasonal Influenza with Vaccines.
Grohskopf LA, Sokolow LZ, Broder KR, Olsen SJ, Karron RA, Jernigan DB, Bresee JS. Grohskopf LA, et al. MMWR Recomm Rep. 2016 Aug 26;65(5):1-54. doi: 10.15585/mmwr.rr6505a1. MMWR Recomm Rep. 2016. PMID: 27560619
The Advisory Committee on Immunization Practices' controversial recommendation against the use of live attenuated influenza vaccine is based on a biased study design that ignores secondary protection.
Small PA Jr, Cronin BJ. Small PA Jr, et al. Vaccine. 2017 Feb 22;35(8):1110-1112. doi: 10.1016/j.vaccine.2017.01.022. Epub 2017 Jan 22. Vaccine. 2017. PMID: 28118937 No abstract available.

1. Small PA Jr, Cronin BJ. The Advisory Committee on Immunization Practices’ controversial recommendation against the use of live attenuated influenza vaccine is based on a biased study design that ignores secondary protection. Vaccine 2017:35:1110–2. - PubMed
1. Grohskopf LA, Sokolow LZ, Broder KR, Olsen SJ, Karron RA, Jernigan DB, et al. Prevention and control of seasonal influenza with vaccines. MMWR Recomm Rep 2016;65:1–54. - PubMed
1. Advisory Committee on Immunization Practices (ACIP). Summary report, June 22–23, 2016. [meeting minutes]. Atlanta, GA: Department of Health and Human Services. Centers for Disease Control and Prevention.
1. Chung JR, Flannery B, Thompson MG, Gaglani M, Jackson ML, Monto AS, et al. Seasonal effectiveness of live attenuated and inactivated influenza vaccine. Pediatrics 2016;137:e20153279. - PMC - PubMed
1. Belshe RB, Edwards KM, Vesikari T, Black SV, Walker RE, Hultquist M, et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007;356:685–96. - PubMed